Changes are happening - please bear with us while we update our site. Click here to give us your advice and feedback.
Looking to broaden your horizons, diversify your portfolio and invest in the mighty US stock market? Here are the latest US stock ideas, stories and news from our team at Rask Media, covering companies on the two largest stock exchanges in the world: the New York Stock Exchange (NYSE) and the NASDAQ.
Another 4% fall in the price of iron ore was almost enough to drive the S&P/ASX200 (INDEXASX: XJO) lower, with the materials sector falling 0.7% to open the week.
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished up +0.11% to 7076.50.
Robert Marfell is the Head of Content at Selfwealth, one of Australia’s largest independent online brokers — with over 120,000 active investors.
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished up +0.051% to 7068.80.
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished down -1.37% to 7065.20.
No matter how experienced an investor you are, the decision of when to invest money can naturally provoke a feeling of uncertainty or apprehension.
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished down -0.46% to 7163.30.
The Resmed CDI (ASX: RMD) share price is down over 30% over the past 12 months as analysts and investors weigh up the long-term impact of GLP-1 treatments on RMD’s obstructive sleep apnea (OSA) market.
Global energy markets will need to evolve dramatically over the next three decades. Worldwide, the population is forecast to grow by nearly 2 billion1 and global living standards are expected to rise as per capita consumption increases – and all this against the backdrop of a growing push towards decarbonisation.
Another 4% fall in the price of iron ore was almost enough to drive the S&P/ASX200 (INDEXASX: XJO) lower, with the materials sector falling 0.7% to open the week.
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished up +0.11% to 7076.50.
Robert Marfell is the Head of Content at Selfwealth, one of Australia’s largest independent online brokers — with over 120,000 active investors.
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished up +0.051% to 7068.80.
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished down -1.37% to 7065.20.
No matter how experienced an investor you are, the decision of when to invest money can naturally provoke a feeling of uncertainty or apprehension.
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished down -0.46% to 7163.30.
The Resmed CDI (ASX: RMD) share price is down over 30% over the past 12 months as analysts and investors weigh up the long-term impact of GLP-1 treatments on RMD’s obstructive sleep apnea (OSA) market.
Global energy markets will need to evolve dramatically over the next three decades. Worldwide, the population is forecast to grow by nearly 2 billion1 and global living standards are expected to rise as per capita consumption increases – and all this against the backdrop of a growing push towards decarbonisation.
Want to level-up your analytical skills and investing insights but don’t know where to start? We can help. Join 40,000+ Australian investors on our mailing list today and we’ll send you our favourite podcasts, courses, resources, investment articles and podcasts every week. Delivered to your inbox every Sunday morning. Grab a coffee and let Owen and the team bring you the best investment insights every week.
